Glenmark Pharmaceuticals Limited Share Price & Analysis
₹2,229Updated 21 Apr 2026, 01:26 pm IST
LTP
₹2,229
—
Open
₹2,221.9
High
₹2,245
Low
₹2,215.2
Close
₹2,230.7
52W High
₹2,298
52W Low
₹2,298
Volume
148K
Lot Size
375
Sector
—
Fundamentals
P/E
23.5
P/B
—
ROE
15.8%
ROCE
19.4%
D/E Ratio
—
Div Yield
0.11%
EPS
—
Book Value
₹340
AI AnalysisGenerated daily after market close · AI-powered
Today's Price Action
Glenmark Pharmaceuticals trades flat at ₹2229, with volume matching the 20-day average of 1.48 L shares, indicating neutral sentiment. Lack of price movement and typical turnover suggest accumulation or indecision.
Valuation Snapshot
Glenmark trades at a P/E of 23.5x, though sector comparison is ineffective due to unavailable sector P/E. A 15.8% ROE reflects solid profitability and efficient capital use for the company.
Key Levels to Watch
The stock hovers just below its 52-week high of ₹2298, with the entire range compressed at ₹2298–₹2298, signaling trading stagnation. Limited spread between high and low underscores range-bound pressure.
Trader Takeaway
Watch for a breakout above ₹2298 on elevated volume—this would confirm bullish momentum and open a target of ₹2400.
Deep Dive Analysis
Related Analysis
Frequently Asked Questions
What is Glenmark Pharmaceuticals Limited share price today?▾
Glenmark Pharmaceuticals Limited (GLENMARK) is currently trading at ₹2,229 on NSE, as of the last market session. Prices update daily after market close on MarketNetra.
Is Glenmark Pharmaceuticals Limited available in F&O (Futures & Options)?▾
Yes, Glenmark Pharmaceuticals Limited (GLENMARK) is part of the NSE F&O segment with a lot size of 375 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Glenmark Pharmaceuticals Limited 52-week high and low?▾
Glenmark Pharmaceuticals Limited's 52-week high is ₹2,298 and the 52-week low is ₹2,298. The current price of ₹2,229 is 3.0% below the 52W high.
What is Glenmark Pharmaceuticals Limited P/E ratio?▾
Glenmark Pharmaceuticals Limited's current P/E ratio is 23.5. This indicates the market is paying ₹23.5 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Glenmark Pharmaceuticals Limited options?▾
Glenmark Pharmaceuticals Limited options are traded on NSE with monthly expiry contracts (lot size: 375 shares). To trade GLENMARK options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.